J
Jianping Liu
Researcher at China Pharmaceutical University
Publications - 125
Citations - 2640
Jianping Liu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 24, co-authored 99 publications receiving 1975 citations.
Papers
More filters
Journal ArticleDOI
Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers
Li Gan,Jing Wang,Jing Wang,Min Jiang,Min Jiang,Hanah Bartlett,Defang Ouyang,Frank Eperjesi,Jianping Liu,Yong Gan +9 more
TL;DR: In this review, the advantages of lipid-based nanocarriers as non-invasive topical ocular drug delivery systems are presented and many systems, including emulsions, liposome, cubosomes, niosomes and other lipid- based nanoccarriers are reviewed.
Journal ArticleDOI
Enhancement of transdermal delivery of theophylline using microemulsion vehicle.
TL;DR: Results of studies showed that microemulsion system of theophylline might be promising vehicles for the transdermal delivery of thephylline.
Journal ArticleDOI
Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology
Xiaoyun Zhang,Xiaoyun Zhang,Jianping Liu,Hua Qiao,Huan Liu,Jingman Ni,Wenli Zhang,Yanbin Shi +7 more
TL;DR: In this article, the central composite rotatable design (CCRD) model was used to optimize formulations of dihydroartemisinin nancistructured lipid carrier (DHA-NLC).
Journal ArticleDOI
Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection
Li Gan,Jing Wang,Jing Wang,Ya-Nan Zhao,Ya-Nan Zhao,Dan Chen,Chunliu Zhu,Jianping Liu,Yong Gan +8 more
TL;DR: A hyaluronan (HA)-modified core-shell liponanoparticles (HA-LCS-NPs) was designed to improve the treatment efficiency by increasing RPE-targeted distribution and prolonged intraocular residence.
Journal ArticleDOI
Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.
TL;DR: In this paper, Discoidal and spherical recombinant HDL loaded with cardiovascular drug tanshinone IIA (TA) were constructed (TA-d-rHDL and TA-s-RHDL), and their in vitro physiochemical and biomimetic properties were characterized.